Medici List crest
Disclaimer: This is a simplified summary of a public company filing. See full disclaimer here.

Churchill Capital Corp IX/Cayman

CIK: 20062912 Annual ReportsLatest: 2026-02-05

10-K / February 5, 2026

Revenue:N/A
Income:$8,556,703

10-K / March 31, 2025

Revenue:N/A
Income:$8,791,874

10-K / February 5, 2026

PlusAI SPAC

Overview

  • Organized as a Cayman Islands exempted company on December 18, 2023 as a blank check company (SPAC).
  • Formed to complete a Business Combination with one or more target businesses in any industry.
  • IPO completed May 6, 2024; gross proceeds from the IPO and a related private placement were placed in a Trust Account to be used for a future Business Combination.
  • Pursuing a Business Combination with PlusAI and will domesticate from the Cayman Islands to Delaware as PlusAI Holdings, Inc. as part of the closing.
  • The company has not generated operating revenues to date.
  • Current management consists of two officers; there are no full-time employees prior to the initial Business Combination.

Funding structure

  • Public Offering
    • Public Units issued: 28,750,000
    • Each Public Unit comprises: 1 Public Share + 1/4 of 1 Public Warrant
    • Over-Allocation Option Units: 3,750,000 (full exercise)
    • Public Unit price: $10.00 per Unit
    • Gross proceeds from IPO: $287,500,000
  • Private Placement
    • Private Placement Units: 725,000
    • Purchase price per unit: $10.00
    • Gross proceeds from Private Placement: $7,250,000
  • Trust Account
    • Total placed from IPO and Private Placement: $287,500,000
    • Includes a Deferred Underwriter Fee of $10,062,500
  • As of December 31, 2025
    • Funds available for a Business Combination: $307,617,399 (before redemptions, Permitted Withdrawals, taxes, and the Deferred Fee)

Planned transaction — PlusAI Business Combination

  • Target: PlusAI
  • Structure
    • Closing will effect a two-step merger in which PlusAI is merged into the domesticated SPAC.
    • Domestication will convert Class B to Class A (one-for-one) and convert warrants to SPAC Warrants; Units will be canceled into SPAC Class A shares plus a fraction of warrants.
    • Post-closing entity name: PlusAI Holdings, Inc., with SPAC Class A Common Stock and SPAC Class B Common Stock (for regulatory voting purposes).
  • Valuation and consideration
    • Equity Value (PlusAI pre-money): $1,200,000,000 (subject to closing adjustments and any net proceeds from PlusAI financing prior to Closing)
    • Exchange Ratio: Equity Value divided by (i) PlusAI common shares outstanding, (ii) PlusAI options/RSUs vested or assumed, and (iii) PlusAI warrants on an as-converted basis; the result divided by $10.00
    • Each PlusAI share converts into SPAC Class A common stock; options/RSUs convert into SPAC Common Stock; warrants convert into SPAC Warrants on a one-for-one basis (subject to the Exchange Ratio and adjustments)
  • Earnout
    • Up to 15,000,000 additional SPAC Common Stock shares (three tranches of 5,000,000) may be issued during the five-year Earnout Period upon achievement of specified price targets.
  • Conditions to Closing
    • Minimum Cash Condition: at least $100,000,000 in Available Closing SPAC Cash (plus any financing, minus redemptions)
    • Regulatory and government approvals and stockholder approvals from both the SPAC and PlusAI
  • Governance and equity
    • PlusAI options and RSUs will be assumed and converted into exchanged options/RSUs for SPAC Common Stock
    • An Amended and Restated Registration Rights Agreement will govern post-closing resale registrations for holders of SPAC securities
    • Ancillary agreements (Voting and Support Agreements, Sponsor Agreement, etc.) will govern pre- and post-closing governance and ownership dynamics

Key timing and milestones

  • Combination Period
    • Must complete the initial Business Combination by May 6, 2026 (36 months from the IPO) or by August 6, 2026 if a letter of intent or agreement is in place by May 6, 2026.
  • Extensions
    • The Combination Period may be extended in accordance with applicable laws and exchange rules via amendments to the Amended and Restated Articles, subject to shareholder approval and potential redemptions.
  • Post-Closing considerations
    • Public Shares may be redeemed for cash at closing at a per-share price equal to the Trust Account balance plus accrued interest, less Permitted Withdrawals
    • Redemptions may occur at a general meeting or via tender offer, at the SPAC’s discretion

Management and operations

  • Sponsors and advisors
    • M. Klein and Company (affiliate of the Sponsor) is involved in sourcing and structuring transactions
    • Archimedes Advisors LLC is an operating partner entity within M. Klein and Company, with strategic and operating partners who are former senior operating executives
  • Operating Partners and compensation
    • Operating Partners may join the acquired company as directors or senior executives after the Business Combination
    • Operating Partners may share in a portion of founders’ and private placement proceeds if a Business Combination is completed
    • Potential conflicts exist due to relationships with M. Klein and Company and other SPACs; governance provisions and independent oversight are described in the agreement materials
  • Employees
    • Two officers currently; no full-time employees are anticipated prior to completing a Business Combination

Operations and revenue

  • To date, the SPAC has not generated operating revenues.
  • Post-Business Combination, revenue and operating performance will depend on the target business (PlusAI) and the terms of the combination.
  • The SPAC is a public company subject to Exchange Act reporting requirements; audited financial statements for the target will be provided as part of proxy or tender materials.

Additional notes

  • Jurisdiction and structure
    • The company is currently a Cayman Islands exempted company and is expected to domesticate to Delaware upon closing of the Business Combination.
    • After domestication, SPAC securities will be governed by Delaware law and the Domesticated SPAC Charter.
  • Going concern
    • There is substantial doubt about the company’s ability to continue as a going concern, tied to the need for additional financing to finalize a Business Combination and the timing of redemptions.